Advertisement
Research in Brief| Volume 4, ISSUE 3, P176-178, August 2003

Gene Expression Profiling to Predict Outcome of Chemotherapy for Early-Stage Breast Cancer

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Perou CM
        • Sorlie T
        • Eisen MB
        • et al.
        Molecular portraits of human breast tumours.
        Nature. 2000; 406: 747-752
        • Sorlie T
        • Perou CM
        • Tibshirani R
        • et al.
        Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
        Proc Natl Acad Sci U S A. 2001; 98: 10869-10874
        • Rosenwald A
        • Wright G
        • Chan WC
        • et al.
        The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
        N Engl J Med. 2002; 346: 1937-1947
        • Alizadeh AA
        • Eisen MB
        • Davis RE
        • et al.
        Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
        Nature. 2000; 403: 503-511
        • Beer DG
        • Kardia SL
        • Huang CC
        • et al.
        Gene-expression profiles predict survival of patients with lung adenocarcinoma.
        Nat Med. 2002; 8: 816-824
        • van de Vijver MJ
        • He YD
        • van't Veer LJ
        • et al.
        A gene-expression signature as a predictor of survival in breast cancer.
        N Engl J Med. 2002; 347: 1999-2009
        • Pusztai L
        • Ayers M
        • Simmans FW
        • et al.
        Emerging science: Prospective validation of gene expression profiling-based prediction of complete pathologic response to neoadjuvant paclitaxel/FAC chemotherapy in breast cancer.
        Proc Am Soc Clin Oncol. 2003; 22 (Abstract #1).: 1
        • Chang JCN
        • Wooten EC
        • Tsimelzon A
        • et al.
        Gene expression patterns for de novo and acquired docetaxel resistance in patients with locally advanced breast cancer.
        Proc Am Soc Clin Oncol. 2003; 22 (Abstract #32).: 9